Analysis of Founder Mutations in Rare Tumors Associated With HBOC Reveals a Novel Association of BRCA2 Mutations + Ampulla of Vater Carcinomas Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Wednesday, August 24, 2016

Analysis of Founder Mutations in Rare Tumors Associated With HBOC Reveals a Novel Association of BRCA2 Mutations + Ampulla of Vater Carcinomas



Open access:
 Analysis of Founder Mutations in Rare Tumors Associated With Hereditary Breast/Ovarian Cancer Reveals a Novel Association of BRCA2 Mutations with Ampulla of Vater Carcinomas

 ....BRCA2 mutations were observed with a frequency of 14.3% in ampulla of Vater carcinomas. In conclusion, taking into account the implications for both the individuals and their family members, we recommend that patients with these neoplasias should be offered BRCA1/BRCA2 genetic testing and we here show that it is feasible to test for founder mutations in archival tumor tissue. Furthermore, we identified for the first time a high frequency of germline BRCA2 mutations in ampullary cancers.

0 comments :

Post a Comment

Your comments?